arrow
C

Claudio Tripodo

University of Palermo
H指数:69
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Coordinated regulation of nuclear integrity and STING trafficking by miR-30d suppresses innate immunity in breast cancer

miR-30d对核完整性和STING运输的协同调控抑制乳腺癌中的天然免疫

2026-10-240
OAAI
Contact percolation governs collective motility via mechano-chemical feedback in heterogeneous breast cancer

接触渗流通过异质性乳腺癌中的力化学反馈调控集体运动

2026-09-080
OAAI
Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche

多模态空间分析揭示髓系定义的ENKTL亚组及其在预后炎性微环境中的肿瘤-髓系协同作用

Leukemia
IF13.4
2026-08-240
OAAI
Mechano-metabolic feedback connects tissue fluidity to mitochondrial DNA–dependent immunity in breast cancer

机械代谢反馈将组织流动性连接到乳腺癌中的线粒体DNA依赖性免疫

2026-05-130
OAAI
Mast cell release of TNF-α indirectly contributes to recalling B cells in the colorectal cancer milieu through the CCL20/CCR6 axis

肥大细胞释放TNF-α通过CCL20/CCR6轴间接促进结直肠癌微环境中的B细胞回忆应答

2026-04-210
OA
The deubiquitinase activity of CYLD is required for B cell differentiation

CYLD的去泛素化酶活性对B细胞分化是必需的。

2026-04-080
OAAI
Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activation

EBV+和EBV- BL微环境中免疫差异:活性氧生成通路和血小板活化作用

2026-03-300
OAAI
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs

ECM诱导的IL-23通过调控Tregs上的PD-1驱动乳腺癌中的免疫抑制

2025-10-030
OAAI
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone

弥漫大B细胞淋巴瘤保留ATR依赖性的生发中心暗区T细胞排斥决定因素

2025-09-160
OA
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models

顺铂和替莫唑胺联合治疗在实验性癌症模型中触发高突变性和免疫监视。

2025-06-120
OA
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study (vol 109, pg 2297, 2024)

苯达莫司汀和利妥昔单抗作为症状性脾 marginal zone 淋巴瘤的一线治疗:长期结局及早期不可测量微小残留病获得的影响——来自 BRISMA/IELSG36 期 II 研究的数据(vol 109, pg 2297, 2024)

2025-04-010
OA
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer

CD36富集在HER2阳性间充质干细胞中,驱动乳腺癌的治疗抵抗性

2025-01-201
OA
Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
2024-08-151
OAAI
IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells

IL-33通过细胞外囊泡驱动的肿瘤细胞重编程刺激嗜酸性粒细胞的抗癌活性

2024-07-271
OAAI
Mechanical stress during confined migration causes aberrant mitoses and c-MYC amplification
2024-07-111
OAAI
Iron capture through CD71 drives perinatal and tumor-associated Treg expansion
2024-07-024
OAAI